High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

BACKGROUND: The mesenchymal–epithelial transition (MET) pathway is frequently altered in tumours. The purpose of our study was to determine the prognostic value of tumour MET expression levels in patients with triple-negative breast cancer (TNBC), in order to strengthen the rationale for targeted th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagouri, F, Bago-Horvath, Z, Rössler, F, Brandstetter, A, Bartsch, R, Papadimitriou, C A, Dimitrakakis, C, Tsigginou, A, Papaspyrou, I, Giannos, A, Dimopoulos, M-A, Filipits, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619063/
https://www.ncbi.nlm.nih.gov/pubmed/23422757
http://dx.doi.org/10.1038/bjc.2013.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619063/
https://www.ncbi.nlm.nih.gov/pubmed/23422757
http://dx.doi.org/10.1038/bjc.2013.31

Ejemplares similares